Transgender Employees Protected By Federal Law Against Discrimination
Client Alert | 1 min read | 03.23.12
The Eleventh Circuit recently held that transgender employees are protected by federal anti-discrimination laws, bolstering employee claims for harassment and discrimination in the workplace. Glenn v. Brumby, Nos. 10-14833, 10-15015 (11th Cir. Dec. 6, 2011). While the plaintiff, as a Georgia state employee, brought her claims of discrimination under the Equal Protection Clause, the Eleventh Circuit used broad language to find that such discrimination was also unlawful under Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. § 2000e et seq. Under the Glenn analysis, the types of prohibited discrimination covered by Title VII in the private workplace would now include discrimination against transgender employees or any employee discriminated against because of his or her perceived "gender nonconformity." Furthermore, many states, cities, and counties have enacted laws prohibiting discrimination on the basis of gender identity or expression. Most recently, Baltimore County, Maryland joined the jurisdictions that provide such protections.
In light of these developments, employers should take time to revisit their anti-discrimination policies and practices. Employers should refresh their training materials to ensure employees and managers recognize, address, and prevent prohibited conduct, and to ensure neutrality in policies that affect employees - such as gender-based dress codes. When an employee undergoes a gender transition, employees should be instructed to avoid any inquiries regarding a transitioning employee's medical history.
Employers should also be familiar with the various state and local laws that address discrimination based on gender identity or expression. These mandates are being implemented with increasing frequency and may catch employers unaware.
Contacts
Insights
Client Alert | 3 min read | 11.17.26
CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs
On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.
Client Alert | 9 min read | 11.17.26
Priorities and Prospects for AI Legislation in the New Congress
Client Alert | 8 min read | 11.16.26
OCC’s AI Examiner Framework: How Banks’ AI Use Can Trigger Legal Liability and Supervisory Exposure
Client Alert | 3 min read | 11.13.26
Massachusetts Trade Secret Preliminary Injunctions: Prove the Harm, Tailor the Relief

